About this trial
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Eligibility criteria
Qualifiers
Age 18 years and older.
Diagnosed with one of the specified pulmonary diseases, or a healthy control
Able to provide written informed consent
Disqualifiers
Inability to tolerate or undergo a lung ultrasound
Extensive chest wall pathology precluding assessment
Unscorable >2 zones per protocol
Withdrawal of consent
Trial design
Treatments tested in this trial
- Lung Ultrasound
Treatment groups
8
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Assiut University
Lead sponsor
Aliae AR Mohamed Hussein [ahussein
Collaborator